Alpha Tau Medical
DRTS
24 hedge funds and large institutions have $3.25M invested in Alpha Tau Medical in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0.77% less ownership
Funds ownership: 2.62% → 1.86% (-0.77%)
11% less funds holding
Funds holding: 27 → 24 (-3)
39% less capital invested
Capital invested by funds: $5.35M → $3.25M (-$2.1M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Caprock Group
Boise,
Idaho
|
+$59.3K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$46.3K |
| 3 |
ACA
Aptus Capital Advisors
Fairhope,
Alabama
|
+$25.4K |
| 4 |
FGG
Financial Guidance Group
Palm Harbor,
Florida
|
+$25.4K |
| 5 |
SAM
Satovsky Asset Management
New York
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$675K |
| 2 |
CCP
Corbin Capital Partners
New York
|
-$414K |
| 3 |
LCS
Levin Capital Strategies
New York
|
-$148K |
| 4 |
ACM
Atalaya Capital Management
New York
|
-$118K |
| 5 |
Renaissance Technologies
New York
|
-$43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$31.1K | -10,556 | Closed |
|
|
STA
27
Summit Trail Advisors
New York
| – | -$30.3K | -10,270 | Closed |
|
28
UBS Group
Zurich,
Switzerland
| – | -$109 | -37 | Closed |
|
DRTS Hedge Fund Activity: Q2 2024 in Review
24 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q2 2024, worth a combined $3.25M — down 39% from $5.35M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DRTS and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Caprock Group, opening a new position worth an estimated $59.3K. The largest seller was Morgan Stanley, cutting an estimated $675K.
- 24 institutional investors held Alpha Tau Medical (DRTS) as of Q2 2024, down from 27 in Q1 2024.
- Funds reported $3.25M of Alpha Tau Medical stock for Q2 2024, down 39% quarter-over-quarter.
- 2 funds opened new Alpha Tau Medical positions in Q2 2024 and 4 closed out, a net change of -2 holders.
- The largest Alpha Tau Medical buyer in Q2 2024 was Caprock Group, an estimated $59.3K added.
- The largest Alpha Tau Medical seller in Q2 2024 was Morgan Stanley, an estimated $675K sold.
Based on aggregated 13F filings for Q2 2024.